Cargando…
Combination of biomarkers for the detection of hepatocellular carcinoma
Autores principales: | Sternby Eilard, Malin, Åberg, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661908/ https://www.ncbi.nlm.nih.gov/pubmed/33209863 http://dx.doi.org/10.21037/atm-20-5798 |
Ejemplares similares
-
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
por: Rizell, Magnus, et al.
Publicado: (2019) -
Targeting population groups with heavier burden of hepatocellular carcinoma incidence: A nationwide descriptive epidemiological study in Sweden
por: Vaz, Juan, et al.
Publicado: (2022) -
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
por: Eilard, Malin Sternby, et al.
Publicado: (2019) -
Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv
por: Henriksson, M., et al.
Publicado: (2019) -
Radiopaque Fiducials Guiding Laparoscopic Resection of Liver Tumors
por: Falkenberg, Mårten, et al.
Publicado: (2021)